Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcomePooja Panwalkar, Sriram Venneti, Jonathan R. Clark et al.|Acta Neuropathologica|2017Cited by 251
Epigenetically defined therapeutic targeting in H3.3G34R/V high-grade gliomasStefan R. Sweha, Sriram Venneti, Arvind Rao et al.|Science Translational Medicine|2021Cited by 37
Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomasMateus Mota, Sriram Venneti, Stefan R. Sweha et al.|Proceedings of the National Academy of Sciences|2023Cited by 25
Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic PathwaysSriram Venneti, Debra Hawes, Abed Rahman Kawakibi et al.|Cancer Discovery|2025Cited by 2
<i>In Silico</i> Prediction of EZHIP Post-Translational Modification Sites and Small-Molecule High-Throughput Screening for Quantitative EZHIP ModulationJimin Moon, Chan Chung|Brain Tumor Research and Treatment|2026Cited by 0